ZAI LAB: Notice of Audit Committee Action and Date of Publication of 2024 Interim Results Announcement
ZAI LAB: OVERSEAS REGULATORY ANNOUNCEMENT - FORM 8-K
ZAI LAB: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
ZAI LAB: GRANT OF SHARE OPTIONS AND RESTRICTED SHARE UNITS
ZAI LAB: (Revised) Next Day Disclosure Return
ZAI LAB: Next Day Disclosure Return
ZAI LAB: Next Day Disclosure Return
ZAI LAB: GRANT OF RESTRICTED SHARES
ZAI LAB: VOTING RESULTS OF ANNUAL GENERAL MEETING
ZAI LAB: OVERSEAS REGULATORY ANNOUNCEMENT - FORM 8-K
ZAI LAB: GRANT OF SHARE OPTIONS AND RESTRICTED SHARE UNITS
ZAI LAB: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
ZAI LAB: INSIDE INFORMATION - CHINA'S NATIONAL MEDICAL PRODUCTS ADMINISTRATION APPROVED XACDURO (SULBACTAM-DURLOBACTAM) FOR HOSPITAL-ACQUIRED AND VENTILATOR-ASSOCIATED PNEUMONIA CAUSED BY ACINETOBACTER BAUMANNII-CALCOACETICUS COMPLEX
ZAI LAB: GRANT OF SHARE OPTIONS AND RESTRICTED SHARE UNITS
ZAI LAB: INSIDE INFORMATION - CHINA''S NATIONAL MEDICAL PRODUCTS ADMINISTRATION APPROVED AUGTYRO (REPOTRECTINIB) FOR TREATMENT OF PATIENTS WITH ROS1-POSITIVE NSCLC
ZAI LAB: OVERSEAS REGULATORY ANNOUNCEMENT - FORM 10-Q
ZAI LAB: UNAUDITED RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 2024 AND CORPORATE UPDATES
ZAI LAB: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
ZAI LAB: PROXY CARD
ZAI LAB: NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
No Data